About us | IDL Biotech
IDL Biotech


Provides knowledge to decision

IDL Biotech is a diagnostic company that develops, produces, and markets In Vitro Diagnostic (IVD) tests worldwide for the health care sector. We are active in the fields of oncology and bacteriology through manufacturing of various tumor markers and a rapid Salmonella typhoid test. IDL Biotech AB is a subsidiary of  Arocell AB.


IDL’s products enable disease diagnosis and prognosis, control of treatment efficiency, and prolong the interval between more invasive patient examinations.


We are located just outside Stockholm, Sweden, where all company functions, including management, sales & marketing, orders & shipping, R&D, production, and quality assurance can be found.


IDL’s products are distributed primarily in Europe and Asia through a network of international business partners.

Our history

In 1988, IDL was founded under the name IDL Immuno Develop Lab. 10 years later the company name was changed to IDL Biotech AB (publ). IDL Biotech AB (publ) has been listed on the Swedish equities market place, Spotlight Stock Market, since 1999 until 2021. In July 2021 was IDL Biotech acquired by the Swedish company Arocell AB.

IDL Biotech

Skip this intro